Diovan (valsartan) significantly reduces risk of restenosis in patients after stent implantation
Val-PREST Study provides further evidence of Diovan's protective effects in cardiovascular disease Basel, London (ots-PRNewswire)- New research, presented at the 4th International Symposium on Angiotensin II Antagonism in London, shows that the highly selective angiotensin receptor blocker (ARB) ...
mehr